Inventor
HU OLIVER YOA-PU
TW16 patents
⚠️ This page may combine multiple inventors who share the name “HU OLIVER YOA-PU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HU OLIVER YOA-PU
4 patentsUS6703398B2Mar 9, 2004
Orally administered analgesic compositions containing nalbuphine
HU OLIVER YOA-PU17 citations81
US6544954B1Apr 8, 2003
Stable galactose injection solutions
HU OLIVER YOA-PU12 citations71
US6680067B2Jan 20, 2004
Controlled-release pharmaceutical preparation containing nalbuphine and a process for preparing the same
HU OLIVER YOA-PU6 citations60
US7169763B2Jan 30, 2007
Cytochrome P450 3A inhibitors and enhancers
HU OLIVER YOA-PU1 citations44
SINEW PHARMA INC
4 patentsUS10456371B2Oct 29, 2019
Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
SINEW PHARMA INC1 citations68
US12083088B2Sep 10, 2024
Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
SINEW PHARMA INC0 citations57
US11285123B2Mar 29, 2022
Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
SINEW PHARMA INC0 citations57
US10925854B2Feb 23, 2021
Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders
SINEW PHARMA INC0 citations38